£1
1 period on recordActive17012324Private limited companyChertsey
STRATEGIC DRUG DEVELOPMENT LTD
Significant control: Marcin Jerzy Mankowski (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Strategic Drug Development Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Strategic Drug Development Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
STRATEGIC DRUG DEVELOPMENT LTD is an active private limited company (company number 17012324) incorporated on 4 February 2026, registered in Chertsey. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 May 2026, showing net assets of £1 and cash of £1.
Peer position · net assets
By net assets it sits in the lower half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Dr Marcin Jerzy Mankowski
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 4 February 2026under 1 yr ago
- Next accounts due
- 29 February 2028in 489 days
- Confirmation statement due
- 18 February 2027in 113 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
£1
1 period on recordNot reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £1 | £1 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1 at 31 May 2026
- Incorporated less than two years agoIncorporated 4 February 2026; no accounts due yet
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 489 days
- Confirmation statement duein 113 days
- Accounts period endNet assets £1 · dormant accounts
- Incorporated
08
Similar companies in Greater London
- TARAVERA BIO LIMITEDRickmansworth · inc. Feb 2026
- CGX TRAINING SOLUTIONS LIMITEDPurley · inc. Feb 2026
- BIOCELLEX LTDRuislip, · inc. Feb 2026
- INTEVIA BIO LIMITEDRadlett · inc. Feb 2026
- ENDORA HEALTH LIMITEDIsleworth · inc. Mar 2026
- QUANTARA CLINICAL RESEARCH GROUP LTDSouth Croydon · inc. Mar 2026
All companies incorporated on 4 February 2026 · in Feb 2026.
09
Reminders for STRATEGIC DRUG DEVELOPMENT LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.